"International Agencies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
International organizations which provide health-related or other cooperative services.
Descriptor ID |
D007390
|
MeSH Number(s) |
N03.540.514
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "International Agencies".
Below are MeSH descriptors whose meaning is more specific than "International Agencies".
This graph shows the total number of publications written about "International Agencies" by people in this website by year, and whether "International Agencies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 0 | 1 |
2002 | 0 | 2 | 2 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2006 | 0 | 3 | 3 |
2007 | 0 | 4 | 4 |
2008 | 2 | 1 | 3 |
2010 | 2 | 4 | 6 |
2011 | 0 | 6 | 6 |
2012 | 2 | 6 | 8 |
2013 | 1 | 5 | 6 |
2014 | 0 | 4 | 4 |
2015 | 1 | 1 | 2 |
2016 | 0 | 5 | 5 |
2017 | 0 | 1 | 1 |
2018 | 0 | 6 | 6 |
2019 | 1 | 4 | 5 |
2020 | 0 | 10 | 10 |
2021 | 0 | 4 | 4 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "International Agencies" by people in Profiles.
-
IARC Perspective on Oral Cancer Prevention. N Engl J Med. 2022 11 24; 387(21):1999-2005.
-
The shared genetic architecture between epidemiological and behavioral traits with lung cancer. Sci Rep. 2021 09 02; 11(1):17559.
-
Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research. Carcinogenesis. 2021 06 21; 42(6):785-793.
-
Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis. Eur J Cancer. 2021 05; 148:411-421.
-
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature. Cancer Med. 2021 04; 10(8):2645-2659.
-
Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020 10 01; 35(10):1761-1769.
-
Rubinstein-Taybi syndrome in diverse populations. Am J Med Genet A. 2020 12; 182(12):2939-2950.
-
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity. Support Care Cancer. 2020 Dec; 28(12):6145-6157.
-
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors. Support Care Cancer. 2020 Dec; 28(12):6119-6128.
-
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors. Support Care Cancer. 2020 Dec; 28(12):6129-6143.